Because translocation RCCs often masquerade as unclassified tumors, especially in younger patients, immunostains for TFE3 and TFEB are routinely performed; nuclear overexpression suggests MiT (microphthalmia-associated transcription) family translocation RCC, which can be confirmed molecularly [73]. This evidence concerns the gene TFEB and renal cell carcinoma.